These escalating cells have been distinguished from developing B cells via the absence of EBV, which could market the very long-expression progress of B cells. These results were being immediately followed by scientific studies, equally in mice and human beings, demonstrating that supernatants derived from lectin-stimulated usual lymphocytes could